LYCOS RETRIEVER 
Hepatitis C: Drugs
built 255 days ago
CRANBERRY TOWNSHIP, Pa., Jan. 14 /PRNewswire/ -- Three Rivers Pharmaceuticals, LLC finalized acquisition of the hepatitis C drug Infergen from Valeant Pharmaceuticals International (NYSE: VRX). Valeant is receiving $91 million from Three Rivers for the procurement.
Source:
Martins says it is too soon to tell if the triple hepatitis C drug combination that includes ribavirin is more effective than the two-drug Zadaxin plus interferon regimen being evaluated in the phase III trials. The company says it expects to report findings from these trials sometime in 2005 and hopes to win FDA approval for the drug within the next year.
Source:
OTTAWA - Health Canada is warning consumers being treated with Sebivo for hepatitis B not to combine the medication with any interferon products because of potentially serious drug interactions. Taking both Sebivo (telbivudine) and interferon may
Source:
You can get hepatitis C if your blood comes into contact with blood from someone who already has the virus. The most common cause of transmission is the sharing of needles and other equipment used to inject illegal drugs. Less common causes of transmission include:
Source:
MORE ABOUT
Drugs